These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23108395)

  • 41. Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures.
    Franciosa G; Smits JGA; Minuzzo S; Martinez-Val A; Indraccolo S; Olsen JV
    Nat Commun; 2021 May; 12(1):2507. PubMed ID: 33947863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling.
    Pinto I; Duque M; Gonçalves J; Akkapeddi P; Oliveira ML; Cabrita R; Yunes JA; Durum SK; Barata JT; Fragoso R
    Oncogene; 2020 Jan; 39(5):975-986. PubMed ID: 31586130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
    Sanchez-Martin M; Ferrando A
    Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.
    Zou J; Li P; Lu F; Liu N; Dai J; Ye J; Qu X; Sun X; Ma D; Park J; Ji C
    J Hematol Oncol; 2013 Jan; 6():3. PubMed ID: 23289374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional mechanisms by the coregulator MAML1.
    Saint Just Ribeiro M; Wallberg AE
    Curr Protein Pept Sci; 2009 Dec; 10(6):570-6. PubMed ID: 19751190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
    Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
    Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
    Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
    Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.
    Paganin M; Ferrando A
    Blood Rev; 2011 Mar; 25(2):83-90. PubMed ID: 20965628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances on NOTCH signaling in T-ALL.
    Tzoneva G; Ferrando AA
    Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotactic Cues for NOTCH1-Dependent Leukemia.
    Piovan E; Tosello V; Amadori A; Zanovello P
    Front Immunol; 2018; 9():633. PubMed ID: 29666622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.
    Trimarchi T; Bilal E; Ntziachristos P; Fabbri G; Dalla-Favera R; Tsirigos A; Aifantis I
    Cell; 2014 Jul; 158(3):593-606. PubMed ID: 25083870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The RNA helicase DDX5 supports mitochondrial function in small cell lung cancer.
    Xing Z; Russon MP; Utturkar SM; Tran EJ
    J Biol Chem; 2020 Jul; 295(27):8988-8998. PubMed ID: 32376686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.
    Cullion K; Draheim KM; Hermance N; Tammam J; Sharma VM; Ware C; Nikov G; Krishnamoorthy V; Majumder PK; Kelliher MA
    Blood; 2009 Jun; 113(24):6172-81. PubMed ID: 19246562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of the Notch pathway mediated by a gamma-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia.
    Tammam J; Ware C; Efferson C; O'Neil J; Rao S; Qu X; Gorenstein J; Angagaw M; Kim H; Kenific C; Kunii K; Leach KJ; Nikov G; Zhao J; Dai X; Hardwick J; Scott M; Winter C; Bristow L; Elbi C; Reilly JF; Look T; Draetta G; Van der Ploeg L; Kohl NE; Strack PR; Majumder PK
    Br J Pharmacol; 2009 Nov; 158(5):1183-95. PubMed ID: 19775282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
    Cardoso BA; Duque M; Gírio A; Fragoso R; Oliveira ML; Allen JR; Martins LR; Correia NC; Silveira AB; Veloso A; Kimura S; Demoen L; Matthijssens F; Jeha S; Cheng C; Pui CH; Grosso AR; Neto JL; De Almeida SF; Van Vlieberghe P; Mullighan CG; Yunes JA; Langenau DM; Pflumio F; Barata JT
    Haematologica; 2024 Jun; 109(6):1713-1725. PubMed ID: 38058200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The notch regulator MAML1 interacts with p53 and functions as a coactivator.
    Zhao Y; Katzman RB; Delmolino LM; Bhat I; Zhang Y; Gurumurthy CB; Germaniuk-Kurowska A; Reddi HV; Solomon A; Zeng MS; Kung A; Ma H; Gao Q; Dimri G; Stanculescu A; Miele L; Wu L; Griffin JD; Wazer DE; Band H; Band V
    J Biol Chem; 2007 Apr; 282(16):11969-81. PubMed ID: 17317671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1.
    Popko-Scibor AE; Lindberg MJ; Hansson ML; Holmlund T; Wallberg AE
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):300-6. PubMed ID: 22100894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
    Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
    Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.